2026 AHA Infective Endocarditis Scientific Statement: Pharmacotherapy Discussion & Commentary
Explore a pharmacist’s perspective on the 2026 AHA infective endocarditis guidelines, including oral antibiotic transitions, lipoglycopeptides, and updated treatment recommendations.